Stephens Inc Myriad Genetics Inc Transaction History

Stephens Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $892,601 - $1.5 Million	-42,647 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$22.08 - $47.08 $126,297 - $269,297	-5,720 Reduced 11.83%	42,647 $1.22 Million
Q2 2019 Aug 01, 2019	BUY	$22.67 - $35.0 $45,271 - $69,895	1,997 Added 4.31%	48,367 $1.34 Million
Q1 2019 May 03, 2019	BUY	$26.93 - $34.7 $113,132 - $145,774	4,201 Added 9.96%	46,370 $1.54 Million
Q4 2018 Feb 11, 2019	SELL	$27.23 - $45.56 $92,282 - $154,402	-3,389 Reduced 7.44%	42,169 $1.23 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $1.71 Million - $2.29 Million	45,558 New	45,558 $2.1 Million
Q3 2017 Nov 08, 2017	SELL	$24.01 - $36.2 $7.38 Million - $11.1 Million	-307,413 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	307,413	307,413 $7.94 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.